Search research articles
Contact Us
Filters
Showing results (1-10 of 48) with videos related to
Page
of 5
Sort By:
Molecular Oncology
|
April 10, 2014
Mass spectrometry based biomarker discovery, verification, and validation--quality assurance and control of protein biomarker assays
Carol E Parker, Christoph H Borchers
Clinical Chemistry
|
October 14, 2010
Improving the biomarker pipeline
Christoph H Borchers, Carol E Parker
Proteomics. Clinical Applications
|
March 10, 2018
The Special Issue: Clinical Proteomics for Precision Medicine
Carol E Parker, Christoph H Borchers
Methods (San Diego, Calif.)
|
November 11, 2015
Editorial
Carol E Parker, Christoph H Borchers
Molecular Biotechnology
|
March 6, 2002
MALDI/MS-based epitope mapping of antigens bound to immobilized antibodies
Carol E Parker, Kenneth B Tomer
Current Opinion in Molecular Therapeutics
|
July 5, 2007
Protein arrays for biomarker discovery
Jennifer D Reid, Carol E Parker, Christoph H Borchers
Bioanalysis
|
November 22, 2013
Pre-analytical and analytical variability in absolute quantitative MRM-based plasma proteomic studies
Andrew J Percy, Carol E Parker, Christoph H Borchers
Clinical Chemistry
|
July 19, 2018
Immuno-MALDI-TOF-MS in the Clinic
René P Zahedi, Carol E Parker, Christoph H Borchers
Journal of the American Chemical Society
|
August 26, 2014
Subzero temperature chromatography and top-down mass spectrometry for protein higher-order structure characterization: method validation and application to therapeutic antibodies
Jingxi Pan, Suping Zhang, Carol E Parker, et al.
Biotechniques
|
March 15, 2006
Absolute quantitation of cancer-related proteins using an MS-based peptide chip
Erin N Warren, Jian Jiang, Carol E Parker, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 48) with videos related to
Sort By:
Page
of 5
Molecular Oncology
|
April 10, 2014
Mass spectrometry based biomarker discovery, verification, and validation--quality assurance and control of protein biomarker assays
Carol E Parker, Christoph H Borchers
Clinical Chemistry
|
October 14, 2010
Improving the biomarker pipeline
Christoph H Borchers, Carol E Parker
Proteomics. Clinical Applications
|
March 10, 2018
The Special Issue: Clinical Proteomics for Precision Medicine
Carol E Parker, Christoph H Borchers
Methods (San Diego, Calif.)
|
November 11, 2015
Editorial
Carol E Parker, Christoph H Borchers
Molecular Biotechnology
|
March 6, 2002
MALDI/MS-based epitope mapping of antigens bound to immobilized antibodies
Carol E Parker, Kenneth B Tomer
Current Opinion in Molecular Therapeutics
|
July 5, 2007
Protein arrays for biomarker discovery
Jennifer D Reid, Carol E Parker, Christoph H Borchers
Bioanalysis
|
November 22, 2013
Pre-analytical and analytical variability in absolute quantitative MRM-based plasma proteomic studies
Andrew J Percy, Carol E Parker, Christoph H Borchers
Clinical Chemistry
|
July 19, 2018
Immuno-MALDI-TOF-MS in the Clinic
René P Zahedi, Carol E Parker, Christoph H Borchers
Journal of the American Chemical Society
|
August 26, 2014
Subzero temperature chromatography and top-down mass spectrometry for protein higher-order structure characterization: method validation and application to therapeutic antibodies
Jingxi Pan, Suping Zhang, Carol E Parker, et al.
Biotechniques
|
March 15, 2006
Absolute quantitation of cancer-related proteins using an MS-based peptide chip
Erin N Warren, Jian Jiang, Carol E Parker, et al.
Page
of 5